Cedric Francois - Chief Executive Officer, Apellis Pharmaceuticals, Inc
As of February 14, 2022
What is Cedric Francois's Net Worth?
The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief Executive Officer, Cedric Francois, is estimated to be about $50.91M . Cedric Francois owns about 1,347,490 units of Apellis Pharmaceuticals, Inc common stock. In the last 4 years at Apellis Pharmaceuticals, Inc, Cedric Francois has sold an estimated value of $6.38M worth.
What is Cedric Francois's Past Insider Trading?
Cedric Francois's largest purchase order was 61,274 units , worth over $131.13K on March 18, 2020. Cedric Francois's largest sale order was 35,638 units , worth over $1.5M on January 17, 2020. In total, Cedric Francois has made about 33 transactions over 4 years of their time at Apellis Pharmaceuticals, Inc. Cedric Francois usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 5,000 units , worth over $260.8K on December 16, 2020.
Cedric Francois
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Cedric Francois's Salary in 2020?
As Chief Executive Officer of Apellis Pharmaceuticals, Inc, Cedric Francois has a total base salary of $618,769 . Cedric Francois received compensation valued at about $9,275,425 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $429,687 , stock awards of $1,523,844 , option awards of $6,703,125 , and
What is Cedric Francois's' Mailing Address?
- Mailing address is 6400 Westwind Way Suite A Crestwood KY 40014 KY
Apellis Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Cedric Francois, M.D., Ph.D. | 2020 | $618,769 | $429,687 | $1,523,844 | $6,703,125 | - | $9,275,425 |
| Cedric Francois, M.D., Ph.D. | 2019 | $560,019 | $427,893 | - | $3,279,270 | - | $4,267,182 |
| Cedric Francois, M.D., Ph.D. | 2018 | $550,000 | $381,562 | - | $3,127,600 | $15,378 | $4,074,540 |
| Timothy Sullivan | 2020 | $430,269 | $244,688 | $518,129 | $2,279,063 | $13,000 | $3,485,149 |
| Timothy Sullivan | 2019 | $386,423 | $214,730 | - | $1,108,650 | $9,500 | $1,719,303 |
| Timothy Sullivan | 2018 | $380,000 | $190,000 | - | $279,250 | $10,502 | $859,752 |
| Pascal Deschatelets, Ph.D. | 2020 | $423,500 | $239,062 | $415,594 | $1,828,125 | $11,801 | $2,918,082 |
| Pascal Deschatelets, Ph.D. | 2019 | $404,077 | $252,608 | - | $1,108,650 | $55,893 | $1,821,228 |
| Pascal Deschatelets, Ph.D. | 2018 | $400,000 | $225,000 | - | $1,228,700 | $8,657 | $1,862,357 |
| Nur Nicholson | 2020 | $138,462 | $150,068 | - | $2,648,750 | $84,874 | $3,022,154 |
| Adam Townsend | 2020 | $430,038 | $217,500 | $415,594 | $1,828,125 | $9,750 | $2,901,007 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm
What are Apellis Pharmaceuticals, Inc's Past Insider Trades?
Apellis Pharmaceuticals, Inc's most recent insider trade came on June 24, 2022 by A. Sinclair Dunlop who sold 15,000 units worth $675K . In the last 5 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $44.04M and bought an estimated value of $94.04M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Federico Grossi, CHIEF MEDICAL OFFICER, Cedric Francois, Chief Executive Officer, and Alec MacHiels, Director .
Apellis Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||